Table 1: Pertinent trends in laboratory investigations and clinical parameters for Cases  1 and  2.

Case  1Case  2
At diagnosisPostoperative1Postchemo1At diagnosisPostoperative1Postchemo1

Total bilirubin 1.99.418.48.43.9
Direct bilirubin1.48.216.46.22.4
Aspartate transaminase (AST)6791116154217982
Alanine transaminase (ALT)314322
Alkaline phosphatase (AlkPhos)37957996617081167
Carcinoembryonic antigen (CEA)178.3271.927700.7
ECOG performance status135130-1

Postoperative and postchemotherapy laboratory investigations were roughly 1 week and 2 weeks apart, respectively.
At diagnosis, laboratory investigations for Case  2 were reportedly within normal limits.